Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSEAM:PLX
NYSEAM:PLXBiotechs

Protalix BioTherapeutics (PLX) Valuation in Focus After EMA Setback on Elfabrio Dosing Schedule

Protalix BioTherapeutics (PLX) saw its stock take a hit after the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative opinion on the revised dosing schedule for Elfabrio, developed with Chiesi Group. See our latest analysis for Protalix BioTherapeutics. Shares of Protalix BioTherapeutics tumbled 22.5% in a day as the market reacted to the EMA’s negative decision, swiftly erasing gains from earlier momentum. Despite this sharp setback, investors who...
SEHK:9660
SEHK:9660Software

Assessing Horizon Robotics After 22% Drop and AI Hardware Market Surge in 2025

Thinking about what to do with Horizon Robotics stock at this crossroad? You’re not alone. The company’s share price has been on a wild ride lately, and for anyone with skin in the game, those big swings can make decisions anything but straightforward. In the past week alone, Horizon Robotics dropped by 11.1%, and over the last 30 days, the stock slipped a notable 22.8%. Yet, if you take a step back, you’ll see the year-to-date return standing strong at 129.3%. That kind of run-up usually...
NasdaqCM:BLNK
NasdaqCM:BLNKElectrical

Blink Charging (BLNK) Expands UK Presence With Major Council EV Contract – What Does This Mean for Growth?

Blink Charging's UK subsidiary was selected by Bradford Council to deploy 104 electric vehicle charging ports in the initial phase of the government-backed Local Electric Vehicle Infrastructure (LEVI) program, with plans to expand up to 1,000 chargers across more than 230 sites over two years. This project not only increases Blink's footprint in the UK public charging network but also provides long-term management and recurring revenue opportunities through its charging app. We'll now...
NasdaqCM:RCEL
NasdaqCM:RCELBiotechs

AVITA Medical (RCEL) Is Down 22.4% After CEO Departure and Revenue Guidance Cut—Has the Thesis Changed?

Earlier this week, AVITA Medical appointed Chairman Cary Vance as Interim CEO following the departure of Jim Corbett and released preliminary third-quarter revenue guidance of approximately US$17 million, while also securing a waiver on its revenue covenant from OrbiMed and initiating a search for a permanent CEO. This leadership transition and concurrent financial updates come as AVITA continues to address operational and reimbursement challenges in its core wound care markets. We will...